These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 27756618)
1. Autophagy prevention sensitizes AKTi-1/2-induced anti-hepatocellular carcinoma cell activity in vitro and in vivo. Zhang Q; Yang M; Qu Z; Zhou J; Jiang Q Biochem Biophys Res Commun; 2016 Nov; 480(3):334-340. PubMed ID: 27756618 [TBL] [Abstract][Full Text] [Related]
2. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway. Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of MEK/ERK activation attenuates autophagy and potentiates pemetrexed-induced activity against HepG2 hepatocellular carcinoma cells. Tong Y; Huang H; Pan H Biochem Biophys Res Commun; 2015 Jan; 456(1):86-91. PubMed ID: 25446102 [TBL] [Abstract][Full Text] [Related]
4. Autophagy inhibition sensitizes KU-0063794-mediated anti-HepG2 hepatocellular carcinoma cell activity in vitro and in vivo. Yongxi T; Haijun H; Jiaping Z; Guoliang S; Hongying P Biochem Biophys Res Commun; 2015 Sep; 465(3):494-500. PubMed ID: 26278819 [TBL] [Abstract][Full Text] [Related]
5. Regulation of SIRT1/AMPK axis is critically involved in gallotannin-induced senescence and impaired autophagy leading to cell death in hepatocellular carcinoma cells. Kwon HY; Kim JH; Kim B; Srivastava SK; Kim SH Arch Toxicol; 2018 Jan; 92(1):241-257. PubMed ID: 28676953 [TBL] [Abstract][Full Text] [Related]
6. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway. He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740 [TBL] [Abstract][Full Text] [Related]
7. Potent effects of dioscin against hepatocellular carcinoma through regulating TP53-induced glycolysis and apoptosis regulator (TIGAR)-mediated apoptosis, autophagy, and DNA damage. Mao Z; Han X; Chen D; Xu Y; Xu L; Yin L; Sun H; Qi Y; Fang L; Liu K; Peng J Br J Pharmacol; 2019 Apr; 176(7):919-937. PubMed ID: 30710454 [TBL] [Abstract][Full Text] [Related]
8. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling. Zou M; Lu N; Hu C; Liu W; Sun Y; Wang X; You Q; Gu C; Xi T; Guo Q Cell Signal; 2012 Aug; 24(8):1722-32. PubMed ID: 22560876 [TBL] [Abstract][Full Text] [Related]
9. Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability. Correa RJ; Valdes YR; Peart TM; Fazio EN; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG Carcinogenesis; 2014 Sep; 35(9):1951-61. PubMed ID: 24562574 [TBL] [Abstract][Full Text] [Related]
10. KU-0060648 inhibits hepatocellular carcinoma cells through DNA-PKcs-dependent and DNA-PKcs-independent mechanisms. Chen MB; Zhou ZT; Yang L; Wei MX; Tang M; Ruan TY; Xu JY; Zhou XZ; Chen G; Lu PH Oncotarget; 2016 Mar; 7(13):17047-59. PubMed ID: 26933997 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells. Yang J; Pi C; Wang G Biomed Pharmacother; 2018 Jul; 103():699-707. PubMed ID: 29680738 [TBL] [Abstract][Full Text] [Related]
12. Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma. Kim MN; Lee SM; Kim JS; Hwang SG Cancer Chemother Pharmacol; 2019 Oct; 84(4):809-817. PubMed ID: 31385002 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma. Zhai B; Hu F; Jiang X; Xu J; Zhao D; Liu B; Pan S; Dong X; Tan G; Wei Z; Qiao H; Jiang H; Sun X Mol Cancer Ther; 2014 Jun; 13(6):1589-98. PubMed ID: 24705351 [TBL] [Abstract][Full Text] [Related]
14. Bafilomycin A1 induces caspase-independent cell death in hepatocellular carcinoma cells via targeting of autophagy and MAPK pathways. Yan Y; Jiang K; Liu P; Zhang X; Dong X; Gao J; Liu Q; Barr MP; Zhang Q; Hou X; Meng S; Gong P Sci Rep; 2016 Nov; 6():37052. PubMed ID: 27845389 [TBL] [Abstract][Full Text] [Related]
15. Dual effects of gossypol on human hepatocellular carcinoma via endoplasmic reticulum stress and autophagy. Zhang G; Wang Z; Chen W; Cao Y; Wu J; Qiang G; Ji A; Wu J; Jiang C Int J Biochem Cell Biol; 2019 Aug; 113():48-57. PubMed ID: 31128260 [TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors promote epithelial-mesenchymal transition in Hepatocellular Carcinoma Xiao Q; Liu H; Wang HS; Cao MT; Meng XJ; Xiang YL; Zhang YQ; Shu F; Zhang QG; Shan H; Jiang GM Theranostics; 2020; 10(22):10245-10261. PubMed ID: 32929346 [TBL] [Abstract][Full Text] [Related]
17. Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells. Wang Y; Han C; Lu L; Magliato S; Wu T Hepatology; 2013 Sep; 58(3):995-1010. PubMed ID: 23504944 [TBL] [Abstract][Full Text] [Related]
18. Bufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cells. Tsai SC; Yang JS; Peng SF; Lu CC; Chiang JH; Chung JG; Lin MW; Lin JK; Amagaya S; Wai-Shan Chung C; Tung TT; Huang WW; Tseng MT Int J Oncol; 2012 Oct; 41(4):1431-42. PubMed ID: 22858649 [TBL] [Abstract][Full Text] [Related]
19. Hydroxypyridinone-Coumarin Inhibits the Proliferation of MHCC97 and HepG2 Human Hepatocellular Carcinoma Cells and Down-Regulates the Phosphoinositide-3 Kinase Pathway. Cui X; Qin X Med Sci Monit; 2020 Mar; 26():e920785. PubMed ID: 32218414 [TBL] [Abstract][Full Text] [Related]
20. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways. Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]